Evidence map›Paper›PMID 32564285›Full record

ArticleMolecular neurobiology2020

The Impact of Mitochondrial Dysfunction on Dopaminergic Neurons in the Olfactory Bulb and Odor Detection.

Thomas Paß, Marlene Aßfalg, Marianna Tolve, Sandra Blaess, Markus Rothermel, Rudolf J Wiesner, Konrad M Ricke

Open access · hybridAbstract read
In one paragraph

Article in Molecular neurobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. HM568 Enhances NADMolecular neurobiology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Olfactory Bulb DToxins · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Thomas PaßCenter for Physiology and Pathophysiology, Institute of Vegetative Physiology, University of Cologne, Cologne, Germany. thomas.pass@uk-koeln.de.ORCID https://orcid.org/0000-0002-9915-7360
Marlene AßfalgCenter for Physiology and Pathophysiology, Institute of Vegetative Physiology, University of Cologne, Cologne, Germany.
Marianna TolveNeurodevelopmental Genetics, Institute of Reconstructive Neurobiology, University of Bonn School of Medicine & University Hospital Bonn, Bonn, Germany.
Sandra BlaessNeurodevelopmental Genetics, Institute of Reconstructive Neurobiology, University of Bonn School of Medicine & University Hospital Bonn, Bonn, Germany.
Markus RothermelInstitute for Biology II, Dept. Chemosensation, AG Neuromodulation, RWTH Aachen University, Aachen, Germany.
Rudolf J WiesnerCenter for Physiology and Pathophysiology, Institute of Vegetative Physiology, University of Cologne, Cologne, Germany.
Konrad M RickeCenter for Physiology and Pathophysiology, Institute of Vegetative Physiology, University of Cologne, Cologne, Germany. kricke@uottawa.ca.
University of Cologne · DEUniversity of Bonn · DERWTH Aachen University · DE

Funding

Deutsche Forschungsgesellschaft BL 767/3-1; Heisenberg Program BL 767/2-1, BL 767/4-1, BL 767/5-1Deutsche Forschungsgesellschaft Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated DiseasesDeutsche Forschungsgesellschaft RO4046/2-1; RO4046/2-2; Emmy Noether Program GRK 2416Deutsche Forschungsgesellschaft SFB 1089/TP B05Deutsche Forschungsgesellschaft SFB 1218/TP B07University of Bonn Maria von Linden-Program
6 · The paper itself

Abstract

Understanding non-motor symptoms of Parkinson's disease is important in order to unravel the underlying molecular mechanisms of the disease. Olfactory dysfunction is an early stage, non-motor symptom which occurs in 95% of Parkinson's disease patients. Mitochondrial dysfunction is a key feature in Parkinson's disease and importantly contributes to the selective loss of dopaminergic neurons the substantia nigra pars compacta. The olfactory bulb, the first olfactory processing station, also contains dopaminergic neurons, which modulate odor information and thereby enable odor detection as well as odor discrimination. MitoPark mice are a genetic model for Parkinson's disease with severe mitochondrial dysfunction, reproducing the differential vulnerability of dopaminergic neurons in the midbrain. These animals were used to investigate the impact of mitochondrial dysfunction on olfactory-related behavior and olfactory bulb dopaminergic neuron survival. Odor detection was severely impaired in MitoPark mice. Interestingly, only the small anaxonic dopaminergic subpopulation, which is continuously replenished by neurogenesis, was moderately reduced in number, much less compared with dopaminergic neurons in the midbrain. As a potential compensatory response, an enhanced mobilization of progenitor cells was found in the subventricular zone. These results reveal a high robustness of dopaminergic neurons located in the olfactory bulb towards mitochondrial impairment, in striking contrast to their midbrain counterparts.

Indexed as

OdorantsAnimalsCell CountDNA-Binding ProteinsDopaminergic NeuronsElectron TransportHigh Mobility Group ProteinsMesencephalonMice, Inbred C57BLMitochondriaNeostriatumNerve DegenerationOlfactory BulbPAX6 Transcription FactorStem CellsSubstantia NigraDNA-Binding ProteinsHigh Mobility Group ProteinsPAX6 Transcription FactorTfam protein, mouseTyrosine 3-MonooxygenaseMitochondrial dysfunctionNeurogenesisOlfactory bulbParkinson’s disease

Identifiers

PMID32564285
PMCPMC7398899
OpenAlexW3036305703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.